PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 990.0
(-1.0%)
IDR 990.0
(-1.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 128.11 Billion IDR | -2.9% |
| 2022 | 131.94 Billion IDR | -28.32% |
| 2021 | 184.07 Billion IDR | 81.41% |
| 2020 | 101.46 Billion IDR | 5.65% |
| 2019 | 96.04 Billion IDR | 16.31% |
| 2018 | 82.57 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 43.47 Billion IDR | 28.22% |
| 2024 Q3 | 32.53 Billion IDR | 16.47% |
| 2024 Q2 | 31.28 Billion IDR | -28.03% |
| 2023 Q2 | 33.19 Billion IDR | -8.01% |
| 2023 Q1 | 36.08 Billion IDR | 5.92% |
| 2023 FY | 128.11 Billion IDR | -2.9% |
| 2023 Q4 | 33.9 Billion IDR | -1.29% |
| 2023 Q3 | 34.34 Billion IDR | 3.48% |
| 2022 Q3 | 39.45 Billion IDR | 69.28% |
| 2022 Q2 | 23.3 Billion IDR | -33.61% |
| 2022 FY | 131.94 Billion IDR | -28.32% |
| 2022 Q1 | 35.1 Billion IDR | 13.87% |
| 2022 Q4 | 34.06 Billion IDR | -13.66% |
| 2021 Q1 | 54.98 Billion IDR | 45.06% |
| 2021 FY | 184.07 Billion IDR | 81.41% |
| 2021 Q4 | 30.83 Billion IDR | -36.41% |
| 2021 Q3 | 48.48 Billion IDR | -2.57% |
| 2021 Q2 | 49.76 Billion IDR | -9.49% |
| 2020 Q4 | 37.9 Billion IDR | 0.0% |
| 2020 FY | 101.46 Billion IDR | 5.65% |
| 2019 FY | 96.04 Billion IDR | 16.31% |
| 2018 FY | 82.57 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Bundamedik Tbk | 582.25 Billion IDR | 77.997% |
| PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -42.896% |
| PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 92.977% |
| PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 93.49% |
| PT Murni Sadar Tbk | 167.6 Billion IDR | 23.563% |
| PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | 75.172% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -70.28% |
| PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | 70.484% |
| PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 96.485% |
| PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | 82.158% |